Phase I-II

Pfizer pours $25m into Vedanta's Phase II IBD study

19-Jan-2021 By Jenni Spinner

The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.

Grifols to launch trial for potential COVID-19 therapy

19-Jan-2021 By Jenni Spinner

The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic.

COVID-19 a ‘catalyst’ for innovation in 2020: Oracle

18-Jan-2021 By Jenni Spinner

A leader from Oracle Health Sciences examines the dynamic, challenging year and highlights creativity and ingenuity displayed by research professionals.

Decentralized trials, remote monitoring continue surging: KCR

18-Jan-2021 By Jenni Spinner

A representative from the global CRO outlines how forces like COVID-19, decentralized studies, globalization and others are driving change in the industry.

Ampio enrolling patients for inhalable COVID-19 Phase I trial

14-Jan-2021 By Jenni Spinner

The immunotherapy-focused firm reports enrollment stands at 55% for its ongoing study exploring viability of Ampion as an inhalable COVID-19 treatment.

Florida doctor pleads guilty to clinical trial data fraud

12-Jan-2021 By Jenni Spinner

A Miami physician has owned up to falsifying research data and patient participation figures for a pediatric asthma trial conducted from 2013 to 2016.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

PRA Health Sciences expands COVID-19 monitoring program

11-Jan-2021 By Jenni Spinner

The CRO is working with PWNHealth and Fulgent Genetics to enhance its monitoring program, including the addition of at-home COVID-19 testing capabilities.

Phesi, Sensyne Health partner on synthetic arm tech for trials

07-Jan-2021 By Jenni Spinner

The two organizations will collaborate on development of synthetic arms for clinical studies, drawing from millions of patient records and trial subject.

Opportunities abound with ‘rescue’ studies: Bioclinica

07-Jan-2021 By Jenni Spinner

An executive with the clinical research tech firm explains that while such studies can be rife with problems, the right approach can yield results.

Syneos Health acquires Illingworth Research Group

05-Jan-2021 By Jenni Spinner

The pharma services and solutions firm has purchased the clinical research home health company to support increasing demand for in-home trials.

Pediatric trial challenges highlighted in patient survey

04-Jan-2021 By Jenni Spinner

Conducted via a partnership between Parexel and CISCRP, the study reveals insights about the needs and concerns of pediatric patients and their families.

Ampio trials explore potential COVID-19 treatment

04-Jan-2021 By Jenni Spinner

The immunology-focused company has launched clinical research exploring the potential of its Ampion drug to treat the virus behind the pandemic.

DNA analysis could pinpoint ‘long haulers’ among COVID-19 patients

23-Dec-2020 By Jenni Spinner

The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.

‘Explosion’ of health data fuels pharma advances: Linguamatics

22-Dec-2020 By Jenni Spinner

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.

Remote patient monitoring platform expands

17-Dec-2020 By Jenni Spinner

The Medical Data Platform, an RPM solution from VivaLNK, handles clinical trials, cardiac monitoring, remote and in-patient monitoring and other tasks.

Going siteless can lead to clinical trial troubles: AiCure

17-Dec-2020 By Jenni Spinner

A leader from the clinical trial solutions firm talks about the drive toward conducting trials without sites, and why that idea might lead to problems.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

Researchers ‘must embrace the change’ in the year ahead: PRA

16-Dec-2020 By Jenni Spinner

The head of the CRO’s Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.

Despite roadblocks, demand for innovative treatments persists: IQVIA

16-Dec-2020 By Jenni Spinner

Look for advances in decentralized trials, data collection, remote monitoring and other areas, says a leader from the research tech solutions firm.

2020 was ‘the year our industry got it right’: pharma veteran

16-Dec-2020 By Jenni Spinner

William Carson says while the past year was full of challenges, embracing AI and other advanced technology led to impressive progress and opportunity.

Rho joins Decentralized Trials and Research Alliance

15-Dec-2020 By Jenni Spinner

The newly formed group seeks to bring together research professionals to accelerate adoption and introduce industry standards in virtual and hybrid trials

Elligo, Cerner join to expand clinical trial reach in communities

15-Dec-2020 By Jenni Spinner

The two firms will work together to broaden the technology, tools, and resources available to hospitals and practices in less-accessible communities.

Sanofi renews WHO partnership on Neglected Tropical Diseases

15-Dec-2020 By Rachel Arthur

Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.

Industry survey delves into wearable device use

14-Dec-2020 By Jenni Spinner

The research (conducted by trial tech provider Litmus Health) shows an indepth picture of wearable device use, top devices, data capture and other factors.

Clinical Ink launches Lunexis ePRO+ platform module

14-Dec-2020 By Jenni Spinner

The clinical trial tech firm has enhanced its electronic patient-reported outcome module, and landed an investment to help promote various technologies.

CROs partner on women’s oncology clinical solutions

10-Dec-2020 By Jenni Spinner

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for women’s cancers.

Medidata: collaboration furthers decentralized trial progress

10-Dec-2020 By Jenni Spinner

Through organizations like the Association of Clinical Research Organizations, clinical research professionals are helping decentralized research evolve.

Current FDA COVID-19 developments

09-Dec-2020 By Jenni Spinner

The agency continues to offer advice, resources and oversight during the pandemic to help develop tests, treatments and other solutions for the virus.

RWE key to boosting trial diversity: Verantos

08-Dec-2020 By Jenni Spinner

A real-world evidence generation expert discusses how clinical trial teams can make use of RWE to help improve diversity and inclusivity in their studies.

Webinar takes in-depth look at the future of clinical research

07-Dec-2020 By Jenni Spinner

OSP's free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.

How has COVID-19 impacted clinical trial data collection?

07-Dec-2020 By Jenni Spinner

A leader from data-centric CRO Quanticate shares perspective on how the pandemic has disrupted trials, and what tools and technologies can keep work going.

Rare-disease foundation backs regenerative research

03-Dec-2020 By Jenni Spinner

CureDuchenne is investing in and collaborating with Mesentech, a company with a prodrug platform designed to selectively deliver therapeutics to bone.

Medable lands $91m to fuel decentralized trial tech

03-Dec-2020 By Jenni Spinner

The Series C funding will be used to help accelerate the research industry’s adoption of decentralized and digital clinical trial technology.

Dive into the digital evolution of clinical trials

01-Dec-2020 By Jenni Spinner

Taking place December 9, the Digital Advances in Clinical Trials webinar covers notable advances in clinical trial technology, and the future of the field.

COVID-19 collaboration to study patient risk via blood

01-Dec-2020 By Jenni Spinner

Health tech specialists GoodCell are working with the New York Blood Center to identify COVID-19 patients with elevated risk of adverse clinical outcomes.

Amgen deploys StudyTeam enrollment software

01-Dec-2020 By Jenni Spinner

The global biopharma is using Reify Health’s StudyTeam software to streamline and automate clinical trial functions, including recruiting and enrollment.

Janssen partners with Koa Health on digital depression treatments

30-Nov-2020 By Jenni Spinner

The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.

COVID-19 fueling decentralized trial surge: Oracle survey

30-Nov-2020 By Jenni Spinner

A recent survey conducted by Oracle reveals trial professionals’ thoughts, feelings and behavior around decentralized research in the face of the pandemic.

Shimmer wearable lands CE certification

25-Nov-2020 By Jenni Spinner

The decentralized trial tech firm’s Verisense inertial measurement unit sensor has received the seal of approval from the Conformitè Europëenne.

Advarra acquires Longboat

25-Nov-2020 By Jenni Spinner

The clinical site services provider continues its series of strategic company purchases by bringing the Irish trial technologies firm under its umbrella.

Scottish biotech outfit launches clinical trials division

24-Nov-2020 By Jenni Spinner

Intelligent Tissue Group has launched its Intelligent Clinical trials facility to help assess the effectiveness and safety of potential new treatments.

Bristol Myers Squibb, Noxopharm to partner on immunotherapy pilot

23-Nov-2020 By Jenni Spinner

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidate’s potential in overcoming resistance of a cancer drug.

ICON: patient-centric trial network showing results

23-Nov-2020 By Jenni Spinner

A leader from the global CRO shares an update on their new Accellacare clinical research network, and perspective on the importance of patient centricity.

Biopharma firm wraps enrollment for Phase II COVID-19 study

19-Nov-2020 By Jenni Spinner

RedHill Biopharma has completed enrollment for its Phase II study exploring the use of opaganib in treating COVID-19 patients that have severe pneumonia.

Decentralized tech reduces COVID-era patient burdens: Rho

18-Nov-2020 By Jenni Spinner

A leader from the CRO discusses how the COVID-19 pandemic has accelerated decentralized adoption, and how such trials lead to benefits for participants.

Trial matching platform connects cancer patient to answers

18-Nov-2020 By Jenni Spinner

According to one New Yorker, encountering the AI-assisted TrialJectory technology helped cut through the uncertainty to provide information and solutions.

Notable, All4Cure launch patient-centric partnership

18-Nov-2020 By Jenni Spinner

The precision medicine firm is joining with the oncology network in an effort to help improve treatment options and outcomes for cancer patients worldwide.

Firma Clinical Research: prioritize patients in your trials

18-Nov-2020 By Jenni Spinner

A leader from the CRO discusses the vital role participants play in a clinical study’s success, and what it truly means to be patient centric.

Pfizer: collaboration key to clinical care

18-Nov-2020 By Jenni Spinner

An expert from the global pharmaceutical firm shares how working with other organizations and putting patients at the center can benefit clinical research.